544611 — Mahamaya Lifesciences Balance Sheet

0.000.00%

Last trade - 00:00

Basic MaterialsHighly SpeculativeMicro CapMomentum Trap

Annual balance sheet for Mahamaya Lifesciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	13.7	30.4	30.1	39.2	394
Net Total Accounts Receivable
Net Total Receivables	132	160	324	516	833
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	333	540	873	1,567	2,664
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	171	178	183	217	288
Net Intangible Assets
Other Long Term Assets
Total Assets	557	779	1,121	1,883	3,103
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	300	477	780	1,315	1,831
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	400	584	873	1,389	1,884
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	157	194	248	494	1,219
Total Liabilities & Shareholders' Equity	557	779	1,121	1,883	3,103
Total Common Shares Outstanding